Paul Sagan is Director of Moderna, Inc.. Currently has a direct ownership of 703 shares of MRNA, which is worth approximately $30,271. The most recent transaction as insider was on Apr 28, 2022, when has been sold 703 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 703
0% 3M change
0% 12M change
Total Value Held $30,271

PAUL SAGAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 28 2022
BUY
Exercise of conversion of derivative security
-
703 Added 50.0%
703 Common Stock

Also insider at

VMW
VMWARE, INC. Technology
CPARU
Catalyst Partners Acquisition Corp. Financial Services
PS

Paul Sagan

Director
Cambridge, MA

Track Institutional and Insider Activities on MRNA

Follow Moderna, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

News

Receive news related to Moderna, Inc.

Track Activities on MRNA